Drug intelligence / Profile preview

Jianpi Tongluo Formula

Development stage: Preclinical
Lead developer: Shanghai Municipal Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Jianpi Tongluo Formula is a Traditional Chinese Medicine (TCM) herbal decoction developed by the Shanghai Traditional Chinese Medicine Hospital. It is primarily investigated for the treatment of patients with stage III colorectal cancer following surgical resection. The formula is designed based on TCM principles of strengthening the spleen (Jianpi) and unblocking the collaterals (Tongluo) to improve clinical outcomes and safety in postoperative recovery. Research into its efficacy includes the analysis of the gut microbiome and metabolomic profiles to understand its systemic impact on cancer patients and its potential to modulate the internal environment to prevent recurrence.

Other names: Jianpi Tongluo Fang

Beyond the preview

Go deeper on Jianpi Tongluo Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jianpi Tongluo Formula.

Explore the full profile